SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001571049-13-000745
Filing Date
2013-09-17
Accepted
2013-09-16 19:32:19
Documents
8
Effectiveness Date
2013-09-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1300354-tgx.htm DEFM14A 3472525
2 GRAPHIC lg_bgl.jpg GRAPHIC 5415
3 GRAPHIC lg_bglpgfoot.jpg GRAPHIC 2914
4 GRAPHIC lg_investorcom.jpg GRAPHIC 9968
5 GRAPHIC lg_theragenicscorp-bw.jpg GRAPHIC 5024
6 GRAPHIC sg_bgl.jpg GRAPHIC 3469
7 GRAPHIC t1300354_pc-1.jpg GRAPHIC 146769
8 GRAPHIC t1300354_pc-2.jpg GRAPHIC 135437
  Complete submission text file 0001571049-13-000745.txt   3900391
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 7702710233
THERAGENICS CORP (Filer) CIK: 0000795551 (see all company filings)

IRS No.: 581528626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-14339 | Film No.: 131099820
SIC: 3825 Instruments For Meas & Testing of Electricity & Elec Signals